Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms

scientific article

Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.42.7.1842
P932PMC publication ID105693
P698PubMed publication ID9661031

P2093author name stringA D Kashuba
A N Nafziger
J S Bertino
P2860cites workPrediction of creatinine clearance from serum creatinineQ29615603
Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing.Q35136143
Gentamicin pharmacokinetics in patients with malignanciesQ36754353
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentrationQ44483617
The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.Q52695343
Pseudomonas Bacteremia: Pharmacologic and Other Bases for Failure of Treatment with GentamicinQ67238838
Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsisQ67281381
Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patientsQ67779622
Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosidesQ69510690
Antibacterial activity in serum and urine as a therapeutic guide in bacterial infectionsQ69733695
Increased burn patient survival with individualized dosages of gentamicinQ70277778
Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumoniaQ70386358
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectpharmacokineticsQ323936
Gram-negative bacteriaQ632006
pharmacodynamicsQ725307
P304page(s)1842-1844
P577publication date1998-07-01
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleDosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms
P478volume42